These effects are mediated by prostaglandin E2 (PGE2), transforming growth factor (TGF)-β) which promote tumor cell proliferation, anti-apoptotic properties, angiogenesis, and chemotherapeutic resistance [13, 14]. This evidence concerns the gene TGFB1 and neoplasm.